Global Molecular Diagnostics Market 2018: Industrial Analysis and Forecasts 2021

Market Synopsis: The meticulous study on the Global Molecular Diagnostics market offers thorough perceptions covering the key development drivers and prominent trends, industry challenges, rising prospects, lucrative opportunities in detail.

Molecular Diagnostics has emerged as one of the largest and fastest growing segment in the IVD industry. It is the most dynamic and transformative areas of diagnostics, leading to advances in research and treatment that are revolutionizing healthcare across a wide range of diseases and health conditions and has been driven by accuracy, high sensitivity, fast turnaround time, easy workflow, and cost–effective testing.

Download Sample PDF Copy: https://goo.gl/bLZWtv

Market Overview of Molecular Diagnostics Industry: The prime objective of this Molecular Diagnostics Market report is to help the user understand the market in terms of its definition, segmentation, market potential, influential trends, and the challenges that the market is facing. Deep researches and analysis were done during the preparation of the report.

On the basis of application, Molecular oncology tests have emerged as a significant rapidly growing market segment. Oncology test controls nearly 25% market share by the year 2021.
Other segments such as infectious diseases test and genetic testing is poised to be remarkable expansion in the near future. Growing demand for infectious diseases and genetic tests is an opportunity for global molecular diagnostics market.
In terms of technology, Biochips/Microarrays is the fastest growing segment and is expected to boom further within the forecast period. FISH & Innovations and PCR based test is expected to grow at the highest CAGR in the coming years.

The global molecular diagnostics market is projected to reach more than US$ 30 Billion by 2021, at a CAGR of XX% from 2016 to 2021.The global market is mainly driven by chronic infections, growing geriatric population, increasing demand for personalized medicines, and R&D activities for biomarker identification equipped with emergence of new technology and applications. In addition, innovations in molecular diagnostics for treating cancer, government support for research and development, and high patient awareness levels are driving the growth of molecular diagnostic market.

Check Discount on Molecular Diagnostics Market Report: https://goo.gl/C1qZMy

On the basis of company, Roche is the leading company with more than 30% market share in the global molecular diagnostics market and is expected to hold its strong position in the market. Becton Dickinson, Myriad Genetics, Abbott and Qiagen is expected to robust market growth in the global molecular diagnostics market.
The Research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data and statistically–supported and industry–validated market data and projections with a suitable set of assumptions and methodology. It provides analysis and information by categories such as 1) Market and Forecast 2) Application Wise Market & Forecast 3) Geographical Market & Forecast 4) Technology Wise Market & Forecast 5) Company Wise Molecular Diagnostics Sales & Forecast 6) Market Growth Drivers & Challenges.

Access Complete Report with TOC, Tables and Figures and Major Companies Profile:
https://goo.gl/4aM5NP

Thanks for reading this article; you can also get individual chapter wise section or region wise report version like Asia, United States, Europe.

About Garner Insights:
Garner Insights is a Market Intelligence and consulting firm with an all-inclusive experience and vast knowledge of the market research industry.
Our vast storage of research reports across various categories, gives you a complete view of the ever changing and developing trends and current topics worldwide. Our constant endeavor is to keep on improving our storage information by providing rich market reports and constantly improving them

Contact Us:
Mr. Kevin Thomas
Direct:
+1 513 549 5911 (US)
+44 203 318 2846 (UK)
Email: sales@garnerinsights.com

This release was published on openPR.